KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
about
Cancer Stem Cell Hierarchy in Glioblastoma MultiformePrognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-AnalysisAccumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cellsKrüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionmaDoxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.Expression of the tumor suppressor Krüppel-like factor 4 as a prognostic predictor for colon cancer.Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneityOncogenesis and induced pluripotency - commonalities of signalling pathwaysPromoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.Characterizing dynamic regulatory programs in mouse lung development and their potential association with tumourigenesis via miRNA-TF-mRNA circuits.Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells.The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma.Krüppel-like factor 4: A new potential biomarker of lung cancerKLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.Role of SPARC in bone remodeling and cancer-related bone metastasis.Krüppel-like factors in cancer progression: three fingers on the steering wheel.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.Pluripotency transcription factors in lung cancer-a review.Kruppel-like factor 4 inhibits non-small cell lung cancer cell growth and aggressiveness by stimulating transforming growth factor-β1-meidated ERK/JNK/NF-κB signaling pathways.Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells.Krüppel-Like Factor 4 Inhibits the Transforming Growth Factor-β1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial CellsPrognostic significance of KLF4 expression in gastric cancer.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.Krüppel-like factor 4 (KLF4): What we currently know.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.Restoration of KLF4 Inhibits Invasion and Metastases of Lung Adenocarcinoma through Suppressing MMP2.SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy.The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth.[Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].
P2860
Q26752312-7FF25973-7918-485C-B09C-04DE74CD4950Q26770931-F2285728-4D29-4514-A7AE-49175CD2C6DBQ33597842-CE71C04F-30AA-403E-9B69-0B22C2EA2FA1Q33888940-5590FD31-F0D8-4842-B145-7338BDDCFF19Q34066627-F5BE515C-6F64-486C-80EF-15E06ADF4297Q34185696-BC4329D7-291D-4C86-8FDF-A421FCA6C80EQ35055173-7EBA13D3-A651-42AF-893A-9003A7F351C9Q35066337-7D91E598-2DB0-48CC-B5BB-67FB550D1388Q35097588-365438FE-D684-443F-9CDE-B36FB77C5ECAQ35101881-A961F4B2-475E-4B2B-AC69-BCAB07FE94B1Q35461584-22CBBDC9-611D-44C7-9048-06A88770D5D6Q36103362-FD71E125-2846-423E-8EFF-651DFD0A5F7AQ36774028-04B6B25A-CE66-42C4-8B90-D45F9819C3B2Q37001925-376DC6EC-4DD9-4A01-8D49-DE8A518E059AQ37619681-946C9277-82F5-4D2B-8F7A-C2D3C36C15B5Q38137862-D92D5EE5-0744-486D-9DBA-4F7E65C3601BQ38178811-370F4032-D14C-421C-86EF-42AC0C0C286CQ38199932-00134897-0EF8-43F5-9436-EAF2F4BC72B1Q38637870-3D50E135-99D3-4270-A33C-9A28732BCE72Q38717810-52E6482A-6FE9-49EF-9C12-AE86E1C7DB52Q38776683-95B5F0A5-440A-4987-93FD-BCA692238CB7Q38797076-1CFECFEB-8025-46FC-B906-141ACDB956A2Q38868138-1CC47D74-2C17-4780-8059-7C1BA19275FFQ38985417-68B1C6D7-FFB2-46FB-92FF-1855B1240751Q39140678-C1E2ACBB-538F-4DF9-B652-D2FBE812F703Q39151066-CB424AB2-8E94-45C1-AC8A-8C3E66DA5FC7Q42362739-D705C373-F351-4992-983A-54E29125E9C0Q47097615-492B78C0-D519-464E-A128-77F848E46C09Q50993362-36C69C4F-61D7-4E3E-82D5-E234CA1EE9C4Q55314501-6041770E-3E28-4336-915C-7A71A303DBEAQ55427213-9192351A-2E98-4AEF-B7E2-8F5440C82684
P2860
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@ast
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@en
type
label
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@ast
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@en
prefLabel
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@ast
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@en
P2093
P2860
P356
P1476
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
@en
P2093
Abujiang Pataer
Bingliang Fang
Stephen G Swisher
Wayne L Hofstetter
Wenxian Hu
Yanbin Zhou
Yihong Zhou
P2860
P304
P356
10.4161/CBT.9.7.11106
P577
2010-04-01T00:00:00Z